Ad Law Access
FDA Signals Increased Cosmetics Oversight through MoCRA Implementation and Other Regulatory Efforts
Last week, FDA touted its achievements in connection with implementing the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) – noting that the agency had “worked tirelessly, mostly using existing resources, to…
FDA Turns Up the Heat on GLP 1 Dupes Sold “For Research Use Only,” Finds Intended Use Suggests Otherwise
Consumer demand for GLP‑1 drugs such as Ozempic and Zepbound continues to surge, fueling rapid growth in the market for GLP-1 drugs and compounded GLP-1 products, as well as supplements that are marketed to have…
From MAHA to Market: FDA and Some Retailers Announcing New Policies on Colors
The Make America Healthy Again (MAHA) movement has already prompted notable changes in federal and state food policy and has prompted regulators, plaintiff’s lawyers, manufacturers, retailers, and consumers to take a…
FDA MAHA Updates: “No Artificial Color” Claims and a New Preservative Safety Reassessment
At the outset of 2026, FDA announced a series of “priority deliverables” for 2026 as part of its Human Foods Program’s (HFP) “critical role in implementing the Trump Administration and HHS Secretary Robert F. Kennedy,…
MAHA Pushback – Court Temporarily Blocks West Virginia’s Dye Ban
In March 2025, West Virginia passed one of the most aggressive Make America Healthy Again (MAHA)-inspired statutes in the country banning a number of FDA-approved food dyes. But its future is now uncertain after a…